BD spinoff Embecta looks to build on 100 years of diabetes technology

Download

This week… one of the oldest diabetes companies is looking ahead – Once part of BD, makers of needles and syringes, Embecta is now working on new technology like a patch pump. I’m talking to CEO Dev Kurdikar about moving the company forward, while still serving the patient community that relies on their established technology.
This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.

Please visit our Sponsors & Partners – they help make the show possible!

Take Control with Afrezza

Omnipod – Simplify Life

Learn about Dexcom

Check out VIVI Cap to protect your insulin from extreme temperatures

Learn more about AG1 from Athletic Greens

Drive research that matters through the T1D Exchange

The best way to keep up with Stacey and the show is by signing up for our weekly newsletter:

Here’s where to find us:

Facebook (Group)

Facebook (Page)

Instagram